Bloomios, Inc. (BLMS) Research

Headquartered in Santa Barbara, California, Bloomios, Inc. was established in 2001 and focuses on the production, promotion, and distribution of cannabidiol (CBD) products. Their comprehensive selection of hemp-derived supplements and cosmetic goods includes edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. These items are made available to customers via both wholesale and retail channels. The company underwent a name change in April 2021, transitioning from its former identity as XLR Medical Corp. to Bloomios, Inc.

Market snapshot

Symbol
BLMS
Price
$0.00
Day change
0.00%
Market cap
$6.4K
P/E ratio
-0.00x
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aida Pharmaceuticals, Inc. (AIDA)
  • American Scientific Resources, Incorporated (ASFX)
  • CEN Biotech, Inc. (CENBF)
  • MJ Holdings, Inc. (MJNE)
  • South American Gold Corp. (SAGD)
  • SES Solar Inc. (SESI)
  • Statera Biopharma, Inc. (STAB)
  • Upper Street Marketing Inc. (UPPR)

Recent insider activity

  • Rohrer Douglas S — trade (550000 shares) on 2022-11-22
  • Rohrer Douglas S — trade (0 shares) on 2022-11-22
  • EMC2 Capital LLC — trade (0 shares) on 2021-12-15
  • daprile bibi — trade (0 shares) on 2021-07-09
  • daprile bibi — trade (95 shares) on 2021-07-09

Open Bloomios, Inc. (BLMS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.